Oxidant/antioxidant Parameters and their Relationship with Chemotherapy in Hodgkin’s Lymphoma  

Oleh:

Kaya, E. ; Keskin, L. ; Aydogdu, I. ; Kuku, I.

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: The Journal of International Medical Research vol. 33 no. 06 (Nov. 2005), page 687-692.
Topik: ABVD; cisplatin; cancer chemotherapy; oxidant; antioxidant; free radicals; Hodgkin's lymphoma; spectrophotometry

Ketersediaan

Perpustakaan FK Nomor Panggil: J11.K.05-06.01 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

This study investigated changing levels of serum oxidant/antioxidant with chemotherapy and their relation to treatment in 34 Hodgkin’s lymphoma patients. The patient population consisted of 19 males and 15 females. Mean age was 30.41 ± 12.08 years. All patients received the adriamycin, bleomycin, vincristine and dexamethasone (ABVD) treatment protocol. Blood samples were taken before treatment, and on days 1 and 7 during treatment for measurement of superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), catalase (CAT), malondialdehyde (MDA), nitric oxide (NO) and enzyme activities. After ABVD treatment, mean free radical levels were increased and antioxidant levels were significantly decreased in the serum. ABVD treatment results in an increase of free radical levels and a decrease of antioxidant levels in the serum of patients with Hodgkin’s lymphoma.

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali